Sitting Down With

Laboratory mouse
#Sitting Down With

How to accelerate mouse model generation without reducing quality

The latest DDW Sitting Down With sponsored podcast features Dominque Bröhl and Evert-Jan Uringa, Scientific Program Managers at Taconic Biosciences, who discuss how mouse model generation can be accelerated without any loss of quality. They offer insight into the latest developments, innovation and challenges in mouse model generation, how… Read More

#Podcasts

#Biopharmaceuticals #Biotechnology #Clinical trials #Covid-19 #Podcast #Sitting Down With

Clinical trials and the growing importance of technology

The latest sponsored DDW Sitting Down With podcast features Lisa Moneymaker and Paul O’Donohoe of Medidata and they talk to us about decentralised clinical trials. Medidata technology has helped to bring Covid-19 vaccines and treatments to market in record timelines and the company was the first to have launched a fully end-to-end Decentralised Clinical Trials (DCT) offering. Read More

#Podcasts

#Sitting Down With

Enhancing the role of multiplexing in high-throughput screening

The latest sponsored DDW Sitting Down With podcast features Paul Wylie, Director of Multiplex at Abcam looking at enhancing the role of multiplexing in high-throughput screening. Among the topics Lu Rahman will be discussing with Wylie will be the key challenges scientists face with biomarker and drug discovery and… Read More

#Podcasts

#Sitting Down With

The Bamlanivimab story – how it reached clinic in eight months

The latest DDW Sponsored Sitting Down With podcast features Bryan Jones, Senior Research Fellow, BioTechnology Discovery Research, Eli Lilly and Co and Dan Bedinger, Application Science Team Lead, Carterra.  Bamlanivimab was the first neutralising monoclonal antibody to receive emergency use authorisation from the FDA as a… Read More

#Podcasts

#Biotherapeutics #Podcast #Sitting Down With

Comparing SDS-PAGE with automated CE-SDS for improved quantitation, reproducibility, and faster sample turn-around time

The latest DDW Sponsored Sitting Down With podcast features Tufan Aydogdu, Field Applications Manager, ProteinSimple, a Bio-Techne brand. Dr. Aydogdu talks us through how the accurate and quantitative analysis of product purity is a fundamental component of effective development of a biotherapeutic protein. But without consistent techniques and high-quality,… Read More

#Podcasts

#Antibodies #Biopharmaceutical #Collaboration #Sitting Down With

Antibody engineering: the importance of collaboration and successful partnerships

The latest DDW Sponsored Sitting Down With podcast features Melina Mathur, Product Manager for Biopharma at Twist Bioscience. Mathur talks about Twist’s antibody expertise, drawing on the company’s experience and looking at the importance of collaboration. Listen to hear Mathur discuss the company philosophy, how the pandemic has affected… Read More

#Podcasts

#Drug discovery #Proteogenomics #Sitting Down With

The importance of proteogenomics in drug discovery

The latest DDW Sponsored Sitting Down With podcast features Anders Mälarstig, Director of Human Genetics, Pfizer. In this podcast he outlines the role of pQTLs in the drug discovery process and the growing importance of proteogenomics Mälarstig  is currently responsible for developing and applying strategies for new drug targets and… Read More

#Podcasts

#Clinical trial #Clinical trials #Data #Sitting Down With

What has the pandemic taught us about clinical trials?

The latest DDW Sponsored Sitting Down With podcast features Raj Indupuri, CEO of eClinical Solutions, and he talks to us about clinical trials. Listen to this podcast to find out why Indupuri believes ‘data is the new fuel that will drive human progress’, the effect of Covid-19 on clinical trials… Read More

#Podcasts

#Coronavirus #Covid-19 #Drug development #Drug discovery #Immunology / Virology & Vaccines #Pandemic #Sitting Down With #Therapeutics

How critical is the part therapeutics have to play in the pandemic?

This DDW Sponsored Sitting Down With episode features Guy Goldberg, Chief Business Officer of RedHill Biopharma. In this episode  – Guy Goldberg discusses COVID-19 therapeutics and their role in the pandemic. Goldberg shares his market insight, the benefits of an orally-administered small molecule tablet for COVID treatment and how the… Read More

#Podcasts